CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 4.89: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.54BCNY971.09M · vs all stocks (USD)
Revenue (TTM)
1.06BCNY157.37M · vs all stocks (USD)
Profit Margin
-37.26%Beta
0.4590xvs all stocks
52-Week Change
-21.14%vs all stocks
Market Capitalization
6.54BCNY971.09M · vs all stocks (USD)
Enterprise Value
6.44BCNY955.76M · vs all stocks (USD)
Forward P/E
4.19xPrice to Sales (TTM)
6.37xPrice to Book (MRQ)
1.68xEnterprise to Revenue
6.07xEnterprise to EBITDA
55.60xGross Margin
28.43%Profit Margin
-37.26%Operating Margin
2.28%Return on Assets (TTM)
-0.67%Return on Equity (TTM)
-9.88%Revenue (TTM)
1.06BCNY157.37M · vs all stocks (USD)
Revenue per Share (TTM)
0.5150CNYUpdated Aug 19, 2026Quarterly Revenue Growth
-30.00%Gross Profit (TTM)
238.95MCNY35.49M · vs all stocks (USD)
EBITDA (TTM)
181.60MCNY26.97M · vs all stocks (USD)
Net Income (TTM)
-394.82MCNY-58.64M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-53.40%Operating Cash Flow (TTM)
251.92MCNY37.41M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
108.44MCNY16.10M · vs all stocks (USD)
5-Year Average Dividend Yield
0.42%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
-60.24MCNYFY2025 · Dec 31, 2025Revenue
1.17BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
857.49MCNYFY2025 · Dec 31, 2025Gross Profit
308.27MCNYFY2025 · Dec 31, 2025Operating Income
15.71MCNY2.33M · vs all stocks (USD)
Pre-tax Income
-367.82MCNYFY2025 · Dec 31, 2025Income Tax Expense
31.50MCNYFY2025 · Dec 31, 2025Net Income
-399.31MCNYFY2025 · Dec 31, 2025EBIT
-359.46MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
181.60MCNYFY2025 · Dec 31, 2025Research & Development
45.07MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
82.35MCNYFY2025 · Dec 31, 2025Other Operating Expenses
17.00MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
5.92MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
8.36MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.1841CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.1841CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
2.06BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
2.06BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-399.31MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
19.49MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-313.39MCNYFY2025 · Dec 31, 2025Free Cash Flow
-475.64MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
584.22MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-399.31MCNYFY2025 · Dec 31, 2025Other Non-cash Items
11.83MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
2.48MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
71.60MCNYFY2025 · Dec 31, 2025Capital Expenditures
-162.24MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.08BCNYFY2025 · Dec 31, 2025Sale of Investments
1.11BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-128.47MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
671.34MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-597.70MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-11.09MCNYFY2025 · Dec 31, 2025Other Financing Charges
-94.08MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-31.54MCNYFY2025 · Dec 31, 2025Shares Outstanding
2.06BSharesUpdated Aug 19, 2026Float Shares
1.02BSharesUpdated Aug 19, 2026% Held by Insiders
51.95%vs all stocks
% Held by Institutions
0.80%vs all stocks
Total Cash (MRQ)
1.07BCNY158.45M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.5170CNYUpdated Aug 19, 2026Total Debt (MRQ)
717.05MCNY106.50M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1811xCurrent Ratio (MRQ)
2.09xBook Value per Share (MRQ)
1.95CNYUpdated Aug 19, 2026Total Assets
4.86BCNY721.96M · vs all stocks (USD)
Total Current Assets
1.79BCNYFY2025 · Dec 31, 2025Total Liabilities
886.97MCNYFY2025 · Dec 31, 2025Total Non-current Assets
3.07BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
84.24MCNYFY2025 · Dec 31, 2025Total Current Liabilities
802.73MCNYFY2025 · Dec 31, 2025Cash
584.15MCNYFY2025 · Dec 31, 2025Cash Equivalents
313.25MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
897.40MCNYFY2025 · Dec 31, 2025Other Short-term Investments
90.00MCNYFY2025 · Dec 31, 2025Accounts Receivable
120.99MCNYFY2025 · Dec 31, 2025Inventory
512.00MCNYFY2025 · Dec 31, 2025Accounts Payable
121.07MCNYFY2025 · Dec 31, 2025Short-term Debt
560.17MCNYFY2025 · Dec 31, 2025Other Current Liabilities
17.39MCNYFY2025 · Dec 31, 2025Long-term Debt
27.86MCNYFY2025 · Dec 31, 2025Common Stock (Book)
2.06BCNYFY2025 · Dec 31, 2025Retained Earnings
786.27MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.97BCNY590.23M · vs all stocks (USD)
52-Week Low
2.78CNYUpdated Aug 19, 202652-Week High
5.11CNYUpdated Aug 19, 202652-Week Change
-21.14%vs all stocks
Beta
0.4590xvs all stocks
50-Day MA
3.26CNYUpdated Aug 19, 2026200-Day MA
3.76CNYUpdated Aug 19, 2026Avg 10-Day Volume
35.45MSharesUpdated Aug 19, 2026Avg 30-Day Volume
38.24MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
-0.1900CNYUpdated Aug 19, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Down-Close Share With Multi-Year Earnings Decrease
Most weeks closed down this year, and earnings and gross profit fell over four.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 4.89: safe zoneNotable
Altman Z-Score: 4.89
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Bide Pharmatech Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Chengdu Kanghua Biological Products Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Seegene, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Suven Life Sciences Ltd.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Kura Oncology Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Chongqing Pharscin Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Vor Biopharma Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Hob Biotech Group Suzhou Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tianjin Tianyao Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Youcare Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Henan Dayou Energy Co., Ltd.
1 interpretationDown-Close Share With Multi-Year Earnings Decrease
Bright Real Estate Group Co., Ltd.
1 interpretationDown-Close Share With Multi-Year Earnings Decrease
Lucky Film Co.
1 interpretationDown-Close Share With Multi-Year Earnings Decrease